WALKER WAYNE REMELL — SEC insider filings
SEC reporting owner CIK 1428761. 52 insider filings on record with FilingPulse; latest filed 2026-11-17.
Transaction summary — filings shown
Covers the 50 most recent of 52 filings on record, filed 2021-04-09 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 7 filings — 28,772 shares, $36,408 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 55.
- Largest priced transaction: sale of 3,250 shares @ $4.30 ($13,970) in Fabric.AI, Inc., filed 2021-08-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Fabric.AI, Inc. (FABC) | Director | 11 | — | 7 legs · 28,772 sh · $36,408 | 7 |
| Outdoor Holding Co (POWW) | Director | 16 | — | — | 16 |
| Petros Pharmaceuticals, Inc. (PTPI) | Director | 10 | — | — | 12 |
| WRAP TECHNOLOGIES, INC. (WRAP) | — | 5 | — | — | 8 |
| PharmaCyte Biotech, Inc. (PMCB) | Director | 5 | — | — | 7 |
| PITNEY BOWES INC /DE/ (PBI) | Director | 3 | — | — | 5 |
Insider filings — WALKER WAYNE REMELL
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-17 | 4 | Outdoor Holding Co (POWW) | Grant/award (A): 60,000 @ $0 | EDGAR |
| 2026-09-23 | 4 | PITNEY BOWES INC /DE/ (PBI) | Option exercise (M): 5,601 @ $0 · Option exercise (M): 5,601 (derivative) @ $0 | EDGAR |
| 2026-08-19 | 4 | Outdoor Holding Co (POWW) | Grant/award (A): 15,000 @ $0 | EDGAR |
| 2026-07-17 | 4/A | PharmaCyte Biotech, Inc. (PMCB) | Other (J): 0 (derivative) | EDGAR |
| 2026-06-18 | 4 | Fabric.AI, Inc. (FABC) | Grant/award (A): 45,042 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Petros Pharmaceuticals, Inc. (PTPI) | Grant/award (A): 375,000 @ $0 | EDGAR |
| 2026-05-19 | 4 | Outdoor Holding Co (POWW) | Grant/award (A): 15,000 @ $1.94 | EDGAR |
| 2026-05-14 | 4 | PITNEY BOWES INC /DE/ (PBI) | Grant/award (A): 6,532 (derivative) @ $0 · Grant/award (A): 18,159 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | PharmaCyte Biotech, Inc. (PMCB) | Grant/award (A): 119,170 (derivative) @ $0 | EDGAR |
| 2026-02-18 | 4 | Outdoor Holding Co (POWW) | Grant/award (A): 15,000 @ $0 | EDGAR |
| 2026-01-02 | 4 | Petros Pharmaceuticals, Inc. (PTPI) | Grant/award (A): 500,000 @ $0 | EDGAR |
| 2025-12-12 | 4 | PharmaCyte Biotech, Inc. (PMCB) | Grant/award (A): 37,500 @ $0 · Tax withholding (F): 16,875 @ $1.02 · Grant/award (A): 63,233 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | Outdoor Holding Co (POWW) | Grant/award (A): 15,000 @ $0 | EDGAR |
| 2025-10-31 | 4 | StableX Technologies, Inc. (SBLX) | Grant/award (A): 22,723 (derivative) @ $0 | EDGAR |
| 2025-09-24 | 4 | PITNEY BOWES INC /DE/ (PBI) | Grant/award (A): 5,601 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Outdoor Holding Co (POWW) | Grant/award (A): 15,000 @ $0 | EDGAR |
| 2025-04-02 | 4 | AMMO, INC. (POWW) | Grant/award (A): 15,000 @ $0 | EDGAR |
| 2025-02-21 | 4 | Petros Pharmaceuticals, Inc. (PTPI) | Grant/award (A): 150,000 @ $0 | EDGAR |
| 2025-01-14 | 4 | AMMO, INC. (POWW) | Grant/award (A): 15,000 @ $0 | EDGAR |
| 2024-12-02 | 4 | AYRO, Inc. (AYRO) | Disposition to issuer (D): 3,520 @ $0 · Grant/award (A): 83,388 @ $0 · Option exercise (M): 55,592 (derivative) @ $0 | EDGAR |
| 2024-10-11 | 4 | AMMO, INC. (POWW) | Grant/award (A): 15,000 @ $0 | EDGAR |
| 2024-07-17 | 4 | PharmaCyte Biotech, Inc. (PMCB) | Grant/award (A): 38,009 (derivative) @ $0 | EDGAR |
| 2024-07-15 | 4 | AMMO, INC. (POWW) | Grant/award (A): 15,000 @ $0 | EDGAR |
| 2024-06-24 | 4 | AMMO, INC. (POWW) | Grant/award (A): 10,000 @ $0 | EDGAR |
| 2024-02-22 | 4 | AMMO, INC. (POWW) | Grant/award (A): 10,000 @ $0 | EDGAR |
| 2023-12-26 | 4 | Petros Pharmaceuticals, Inc. (PTPI) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-11-22 | 4 | PharmaCyte Biotech, Inc. (PMCB) | Grant/award (A): 61,248 (derivative) @ $0 | EDGAR |
| 2023-11-16 | 4 | AMMO, INC. (POWW) | Grant/award (A): 10,000 @ $0 | EDGAR |
| 2023-10-19 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 10,083 · Grant/award (A): 21,607 | EDGAR |
| 2023-08-03 | 4 | AYRO, Inc. (AYRO) | Sale (S): 7,274 @ $0.82 | EDGAR |
| 2023-08-01 | 4 | AMMO, INC. (POWW) | Grant/award (A): 10,000 @ $0 | EDGAR |
| 2023-07-10 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 10,360 | EDGAR |
| 2023-05-25 | 4 | AMMO, INC. (POWW) | Grant/award (A): 6,413 @ $0 | EDGAR |
| 2023-05-05 | 4 | AYRO, Inc. (AYRO) | Sale (S): 6,810 @ $0.49 | EDGAR |
| 2023-04-28 | 4 | Petros Pharmaceuticals, Inc. (PTPI) | Option exercise (M): 6,050 · Option exercise (M): 6,050 (derivative) @ $0 | EDGAR |
| 2023-04-14 | 4 | AMMO, INC. (POWW) | Grant/award (A): 10,000 @ $0 | EDGAR |
| 2023-04-12 | 4 | Petros Pharmaceuticals, Inc. (PTPI) | Grant/award (A): 39,000 (derivative) @ $0 | EDGAR |
| 2023-04-05 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 8,794 | EDGAR |
| 2023-03-08 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 8,950 | EDGAR |
| 2023-02-03 | 4 | AYRO, Inc. (AYRO) | Sale (S): 4,094 @ $0.71 · Grant/award (A): 112,667 @ $0 | EDGAR |
| 2023-01-25 | 4 | Petros Pharmaceuticals, Inc. (PTPI) | Option exercise (M): 2,264 · Option exercise (M): 2,264 (derivative) @ $0 | EDGAR |
| 2022-11-18 | 4 | WRAP TECHNOLOGIES, INC. (WRAP) | Grant/award (A): 5,602 · Grant/award (A): 8,132 · Grant/award (A): 8,845 | EDGAR |
| 2022-11-03 | 4 | AYRO, Inc. (AYRO) | Sale (S): 4,094 @ $0.59 | EDGAR |
| 2022-04-11 | 4 | Petros Pharmaceuticals, Inc. (PTPI) | Grant/award (A): 60,505 (derivative) @ $0 | EDGAR |
| 2022-02-03 | 4 | AYRO, Inc. (AYRO) | Grant/award (A): 65,504 @ $0 | EDGAR |
| 2022-01-07 | 4 | AYRO, Inc. (AYRO) | Sale (S): 1,625 @ $1.63 | EDGAR |
| 2022-01-07 | 4 | Petros Pharmaceuticals, Inc. (PTPI) | Grant/award (A): 22,642 (derivative) @ $0 | EDGAR |
| 2021-10-07 | 4 | AYRO, Inc. (AYRO) | Sale (S): 1,625 @ $3.20 | EDGAR |
| 2021-08-09 | 4 | AYRO, Inc. (AYRO) | Sale (S): 3,250 @ $4.30 | EDGAR |
| 2021-04-09 | 4 | Petros Pharmaceuticals, Inc. (PTPI) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1428761 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs